0001181431-13-010283.txt : 20130219 0001181431-13-010283.hdr.sgml : 20130219 20130215203521 ACCESSION NUMBER: 0001181431-13-010283 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130215 FILED AS OF DATE: 20130215 DATE AS OF CHANGE: 20130215 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SIMONTON PAMELA A CENTRAL INDEX KEY: 0001202103 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30235 FILM NUMBER: 13621204 MAIL ADDRESS: STREET 1: C/O EXELIXIS INC STREET 2: 170 HARBOR WAY CITY: SAN FRANCISCO STATE: CA ZIP: 94083 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: EXELIXIS, INC. CENTRAL INDEX KEY: 0000939767 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 043257395 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 210 E. GRAND AVE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 6508377000 MAIL ADDRESS: STREET 1: 210 E. GRAND AVE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: EXELIXIS INC DATE OF NAME CHANGE: 20000207 FORMER COMPANY: FORMER CONFORMED NAME: EXELIXIS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20000106 4 1 rrd370504.xml X0306 4 2013-02-15 0 0000939767 EXELIXIS, INC. EXEL 0001202103 SIMONTON PAMELA A C/O EXELIXIS, INC. 210 E. GRAND AVE. SOUTH SAN FRANCISCO CA 94080 0 1 0 0 EVP and General Counsel Common Stock 2013-02-15 4 M 0 1875 0 A 14507 D Common Stock 2013-02-15 4 F 0 879 0 D 13628 D Common Stock 8386 I By 401(K) Restricted Stock Units 2013-02-15 4 M 0 1875 D Common Stock 1875 9375 D Represents the conversion upon vesting of restricted stock units into common stock (the "Converted Common Stock"). On December 9, 2009, the reporting person was granted 30,000 restricted stock units, of which 1/16th of the shares subject to the restricted stock units vested on February 15, 2013. Such restricted stock units were previously reported in Table II on a Form 4 filed with the Securities and Exchange Commission on December 11, 2009. The reporting person is reporting the withholding by Exelixis, Inc. of 879 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the delivery of the Converted Common Stock to the reporting person on February 15, 2013. Represents 8,386 shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of February 14, 2013. Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock. On December 9, 2009, the reporting person was granted 30,000 restricted stock units, of which 1/16th of the shares subject to the restricted stock units vested on February 15, 2013. The common stock into which such vested restricted stock units converted on February 15, 2013 is reported in Table I on this Form 4. The remaining unvested restricted stock units will continue to vest as to 1/16th of the original number of shares subject to the restricted stock units on each succeeding May 15, August 15, November 15 and February 15 until fully vested. /s/ James B. Bucher, Attorney in Fact 2013-02-15